According to Market IntelliX Research, the global market for Precision Cancer Therapeutics should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

China Precision Cancer Therapeutics market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

The United States Precision Cancer Therapeutics market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

In terms of type, Monoclonal Antibodies segment holds a share about % in 2023 and will reach % in 2030; while in terms of application, Breast Cancer has a share approximately % in 2023 and will grow at a CAGR % during 2024 and 2030.

The global key manufacturers of Precision Cancer Therapeutics include AbbVie, Astellas Pharma U.S., Inc, AstraZeneca PLC, Bayer AG, Bristol-Myers Squibb Company, Clovis Oncology, Inc., Dendreon Pharmaceuticals LLC, Eli Lilly & Company and EMD Serono, Inc. (Merck KgaA), etc. In 2023, the global top five players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive study of the global market for Precision Cancer Therapeutics. Report Highlights:

(1) Global Precision Cancer Therapeutics market size (value),history data from 2019-2024 and forecast data from 2024 to 2030.

(2) Global Precision Cancer Therapeutics market competitive situation, revenue and market share, from 2018 to 2022.

(3) China Precision Cancer Therapeutics market competitive situation, revenue and market share, from 2018 to 2022.

(4) Global Precision Cancer Therapeutics segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Precision Cancer Therapeutics segment by type and by application and regional segment by type and by application.

(6) Precision Cancer Therapeutics industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Monoclonal Antibodies

Kinase Inhibitors

Angiogenesis Inhibitors

Proteasome Inhibitors

CAR-T Therapies

Other Precision Therapies

Market segment by application, can be divided into

Breast Cancer

Lung Cancer

Prostate Cancer

Colon and Rectal Cancer

Others

Market segment by players, this report covers

AbbVie

Astellas Pharma U.S., Inc

AstraZeneca PLC

Bayer AG

Bristol-Myers Squibb Company

Clovis Oncology, Inc.

Dendreon Pharmaceuticals LLC

Eli Lilly & Company

EMD Serono, Inc. (Merck KgaA)

Eisai Co., Ltd.

Exelixis, Inc.

Gilead Sciences, Inc.

GlaxoSmithKline

Johnson & Johnson

Merck & Co., Inc.

Novartis AG

Otsuka Holdings Co., Ltd.

Pfizer, Inc.

Puma Biotechnology, Inc.

Roche (F. Hoffman-La Roche, Ltd.)

Sanofi/Genzyme

Seagen Inc.

Takeda

1 Market Overview

1.1 Product Overview and Scope of Precision Cancer Therapeutics

1.2 Global Precision Cancer Therapeutics Market Size and Forecast

1.3 China Precision Cancer Therapeutics Market Size and Forecast

1.4 China Market Percentage in Global

1.4.1 By Revenue, China Precision Cancer Therapeutics Share in Global Market, 2019-2030

1.4.2 Precision Cancer Therapeutics Market Size: China VS Global, 2019-2030

1.5 Precision Cancer Therapeutics Market Dynamics

1.5.1 Precision Cancer Therapeutics Market Drivers

1.5.2 Precision Cancer Therapeutics Market Restraints

1.5.3 Precision Cancer Therapeutics Industry Trends

1.5.4 Precision Cancer Therapeutics Industry Policy

2 Global Competitive Situation by Company

2.1 Global Precision Cancer Therapeutics Revenue by Company (2019-2024)

2.2 Global Precision Cancer Therapeutics Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.3 Global Precision Cancer Therapeutics Concentration Ratio

2.4 Global Precision Cancer Therapeutics Mergers & Acquisitions, Expansion Plans

2.5 Global Precision Cancer Therapeutics Manufacturers Product Type

3 China Competitive Situation by Company

3.1 China Precision Cancer Therapeutics Revenue by Company (2019-2024)

3.2 China Precision Cancer Therapeutics Precision Cancer Therapeutics Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.3 China Precision Cancer Therapeutics, Revenue Percentage of Local Players VS Foreign Manufacturers (2019-2024)

4 Industry Chain Analysis

4.1 Precision Cancer Therapeutics Industry Chain

4.2 Precision Cancer Therapeutics Upstream Analysis

4.3 Precision Cancer Therapeutics Midstream Analysis

4.4 Precision Cancer Therapeutics Downstream Analysis

5 Sights by Type

5.1 Precision Cancer Therapeutics Classification

5.1.1 Monoclonal Antibodies

5.1.2 Kinase Inhibitors

5.1.3 Angiogenesis Inhibitors

5.1.4 Proteasome Inhibitors

5.1.5 CAR-T Therapies

5.1.6 Other Precision Therapies

5.2 By Type, Global Precision Cancer Therapeutics Market Size & CAGR, 2019 VS 2024 VS 2030

5.3 By Type, Global Precision Cancer Therapeutics Revenue, 2019-2030

6 Sights by Application

6.1 Precision Cancer Therapeutics Segment by Application

6.1.1 Breast Cancer

6.1.2 Lung Cancer

6.1.3 Prostate Cancer

6.1.4 Colon and Rectal Cancer

6.1.5 Others

6.2 By Application, Global Precision Cancer Therapeutics Market Size & CAGR, 2019 VS 2024 VS 2030

6.3 By Application, Global Precision Cancer Therapeutics Revenue, 2019-2030

7 Sales Sights by Region

7.1 By Region, Global Precision Cancer Therapeutics Market Size, 2019 VS 2024 VS 2030

7.2 By Region, Global Precision Cancer Therapeutics Market Size, 2019-2030

7.3 North America

7.3.1 North America Precision Cancer Therapeutics Market Size & Forecasts, 2019-2030

7.3.2 By Country, North America Precision Cancer Therapeutics Market Size Market Share

7.4 Europe

7.4.1 Europe Precision Cancer Therapeutics Market Size & Forecasts, 2019-2030

7.4.2 By Country, Europe Precision Cancer Therapeutics Market Size Market Share

7.5 Asia Pacific

7.5.1 Asia Pacific Precision Cancer Therapeutics Market Size & Forecasts, 2019-2030

7.5.2 By Country/Region, Asia Pacific Precision Cancer Therapeutics Market Size Market Share

7.6 South America

7.6.1 South America Precision Cancer Therapeutics Market Size & Forecasts, 2019-2030

7.6.2 By Country, South America Precision Cancer Therapeutics Market Size Market Share

7.7 Middle East & Africa

8 Sights by Country Level

8.1 By Country, Global Precision Cancer Therapeutics Market Size & CAGR，2019 VS 2024 VS 2030

8.2 By Country, Global Precision Cancer Therapeutics Market Size, 2019-2030

8.3 U.S.

8.3.1 U.S. Precision Cancer Therapeutics Market Size, 2019-2030

8.3.2 By Company, U.S. Precision Cancer Therapeutics Revenue Market Share, 2019-2024

8.3.3 By Type, U.S. Precision Cancer Therapeutics Revenue Market Share, 2023 VS 2030

8.3.4 By Application, U.S. Precision Cancer Therapeutics Revenue Market Share, 2023 VS 2030

8.4 Europe

8.4.1 Europe Precision Cancer Therapeutics Market Size, 2019-2030

8.4.2 By Company, Europe Precision Cancer Therapeutics Revenue Market Share, 2019-2024

8.4.3 By Type, Europe Precision Cancer Therapeutics Revenue Market Share, 2023 VS 2030

8.4.4 By Application, Europe Precision Cancer Therapeutics Revenue Market Share, 2023 VS 2030

8.5 China

8.5.1 China Precision Cancer Therapeutics Market Size, 2019-2030

8.5.2 By Company, China Precision Cancer Therapeutics Revenue Market Share, 2019-2024

8.5.3 By Type, China Precision Cancer Therapeutics Revenue Market Share, 2023 VS 2030

8.5.4 By Application, China Precision Cancer Therapeutics Revenue Market Share, 2023 VS 2030

8.6 Japan

8.6.1 Japan Precision Cancer Therapeutics Market Size, 2019-2030

8.6.2 By Company, Japan Precision Cancer Therapeutics Revenue Market Share, 2019-2024

8.6.3 By Type, Japan Precision Cancer Therapeutics Revenue Market Share, 2023 VS 2030

8.6.4 By Application, Japan Precision Cancer Therapeutics Revenue Market Share, 2023 VS 2030

8.7 South Korea

8.7.1 South Korea Precision Cancer Therapeutics Market Size, 2019-2030

8.7.2 By Company, South Korea Precision Cancer Therapeutics Revenue Market Share, 2019-2024

8.7.3 By Type, South Korea Precision Cancer Therapeutics Revenue Market Share, 2023 VS 2030

8.7.4 By Application, South Korea Precision Cancer Therapeutics Revenue Market Share, 2023 VS 2030

8.8 Southeast Asia

8.8.1 Southeast Asia Precision Cancer Therapeutics Market Size, 2019-2030

8.8.2 By Company, Southeast Asia Precision Cancer Therapeutics Revenue Market Share, 2019-2024

8.8.3 By Type, Southeast Asia Precision Cancer Therapeutics Revenue Market Share, 2023 VS 2030

8.8.4 By Application, Southeast Asia Precision Cancer Therapeutics Revenue Market Share, 2023 VS 2030

8.9 India

8.9.1 India Precision Cancer Therapeutics Market Size, 2019-2030

8.9.2 By Company, India Precision Cancer Therapeutics Revenue Market Share, 2019-2024

8.9.3 By Type, India Precision Cancer Therapeutics Revenue Market Share, 2023 VS 2030

8.9.4 By Application, India Precision Cancer Therapeutics Revenue Market Share, 2023 VS 2030

8.10 Middle East & Asia

8.10.1 Middle East & Asia Precision Cancer Therapeutics Market Size, 2019-2030

8.10.2 By Company, Middle East & Asia Precision Cancer Therapeutics Revenue Market Share, 2019-2024

8.10.3 By Type, Middle East & Asia Precision Cancer Therapeutics Revenue Market Share, 2023 VS 2030

8.10.4 By Application, Middle East & Asia Precision Cancer Therapeutics Revenue Market Share, 2023 VS 2030

9 Global Manufacturers Profile

9.1 AbbVie

9.1.1 AbbVie Company Information, Head Office, Market Area and Industry Position

9.1.2 AbbVie Company Profile and Main Business

9.1.3 AbbVie Precision Cancer Therapeutics Models, Specifications and Application

9.1.4 AbbVie Precision Cancer Therapeutics Revenue and Gross Margin, 2019-2024

9.1.5 AbbVie Recent Developments

9.2 Astellas Pharma U.S., Inc

9.2.1 Astellas Pharma U.S., Inc Company Information, Head Office, Market Area and Industry Position

9.2.2 Astellas Pharma U.S., Inc Company Profile and Main Business

9.2.3 Astellas Pharma U.S., Inc Precision Cancer Therapeutics Models, Specifications and Application

9.2.4 Astellas Pharma U.S., Inc Precision Cancer Therapeutics Revenue and Gross Margin, 2019-2024

9.2.5 Astellas Pharma U.S., Inc Recent Developments

9.3 AstraZeneca PLC

9.3.1 AstraZeneca PLC Company Information, Head Office, Market Area and Industry Position

9.3.2 AstraZeneca PLC Company Profile and Main Business

9.3.3 AstraZeneca PLC Precision Cancer Therapeutics Models, Specifications and Application

9.3.4 AstraZeneca PLC Precision Cancer Therapeutics Revenue and Gross Margin, 2019-2024

9.3.5 AstraZeneca PLC Recent Developments

9.4 Bayer AG

9.4.1 Bayer AG Company Information, Head Office, Market Area and Industry Position

9.4.2 Bayer AG Company Profile and Main Business

9.4.3 Bayer AG Precision Cancer Therapeutics Models, Specifications and Application

9.4.4 Bayer AG Precision Cancer Therapeutics Revenue and Gross Margin, 2019-2024

9.4.5 Bayer AG Recent Developments

9.5 Bristol-Myers Squibb Company

9.5.1 Bristol-Myers Squibb Company Company Information, Head Office, Market Area and Industry Position

9.5.2 Bristol-Myers Squibb Company Company Profile and Main Business

9.5.3 Bristol-Myers Squibb Company Precision Cancer Therapeutics Models, Specifications and Application

9.5.4 Bristol-Myers Squibb Company Precision Cancer Therapeutics Revenue and Gross Margin, 2019-2024

9.5.5 Bristol-Myers Squibb Company Recent Developments

9.6 Clovis Oncology, Inc.

9.6.1 Clovis Oncology, Inc. Company Information, Head Office, Market Area and Industry Position

9.6.2 Clovis Oncology, Inc. Company Profile and Main Business

9.6.3 Clovis Oncology, Inc. Precision Cancer Therapeutics Models, Specifications and Application

9.6.4 Clovis Oncology, Inc. Precision Cancer Therapeutics Revenue and Gross Margin, 2019-2024

9.6.5 Clovis Oncology, Inc. Recent Developments

9.7 Dendreon Pharmaceuticals LLC

9.7.1 Dendreon Pharmaceuticals LLC Company Information, Head Office, Market Area and Industry Position

9.7.2 Dendreon Pharmaceuticals LLC Company Profile and Main Business

9.7.3 Dendreon Pharmaceuticals LLC Precision Cancer Therapeutics Models, Specifications and Application

9.7.4 Dendreon Pharmaceuticals LLC Precision Cancer Therapeutics Revenue and Gross Margin, 2019-2024

9.7.5 Dendreon Pharmaceuticals LLC Recent Developments

9.8 Eli Lilly & Company

9.8.1 Eli Lilly & Company Company Information, Head Office, Market Area and Industry Position

9.8.2 Eli Lilly & Company Company Profile and Main Business

9.8.3 Eli Lilly & Company Precision Cancer Therapeutics Models, Specifications and Application

9.8.4 Eli Lilly & Company Precision Cancer Therapeutics Revenue and Gross Margin, 2019-2024

9.8.5 Eli Lilly & Company Recent Developments

9.9 EMD Serono, Inc. (Merck KgaA)

9.9.1 EMD Serono, Inc. (Merck KgaA) Company Information, Head Office, Market Area and Industry Position

9.9.2 EMD Serono, Inc. (Merck KgaA) Company Profile and Main Business

9.9.3 EMD Serono, Inc. (Merck KgaA) Precision Cancer Therapeutics Models, Specifications and Application

9.9.4 EMD Serono, Inc. (Merck KgaA) Precision Cancer Therapeutics Revenue and Gross Margin, 2019-2024

9.9.5 EMD Serono, Inc. (Merck KgaA) Recent Developments

9.10 Eisai Co., Ltd.

9.10.1 Eisai Co., Ltd. Company Information, Head Office, Market Area and Industry Position

9.10.2 Eisai Co., Ltd. Company Profile and Main Business

9.10.3 Eisai Co., Ltd. Precision Cancer Therapeutics Models, Specifications and Application

9.10.4 Eisai Co., Ltd. Precision Cancer Therapeutics Revenue and Gross Margin, 2019-2024

9.10.5 Eisai Co., Ltd. Recent Developments

9.11 Exelixis, Inc.

9.11.1 Exelixis, Inc. Company Information, Head Office, Market Area and Industry Position

9.11.2 Exelixis, Inc. Company Profile and Main Business

9.11.3 Exelixis, Inc. Precision Cancer Therapeutics Models, Specifications and Application

9.11.4 Exelixis, Inc. Precision Cancer Therapeutics Revenue and Gross Margin, 2019-2024

9.11.5 Exelixis, Inc. Recent Developments

9.12 Gilead Sciences, Inc.

9.12.1 Gilead Sciences, Inc. Company Information, Head Office, Market Area and Industry Position

9.12.2 Gilead Sciences, Inc. Company Profile and Main Business

9.12.3 Gilead Sciences, Inc. Precision Cancer Therapeutics Models, Specifications and Application

9.12.4 Gilead Sciences, Inc. Precision Cancer Therapeutics Revenue and Gross Margin, 2019-2024

9.12.5 Gilead Sciences, Inc. Recent Developments

9.13 GlaxoSmithKline

9.13.1 GlaxoSmithKline Company Information, Head Office, Market Area and Industry Position

9.13.2 GlaxoSmithKline Company Profile and Main Business

9.13.3 GlaxoSmithKline Precision Cancer Therapeutics Models, Specifications and Application

9.13.4 GlaxoSmithKline Precision Cancer Therapeutics Revenue and Gross Margin, 2019-2024

9.13.5 GlaxoSmithKline Recent Developments

9.14 Johnson & Johnson

9.14.1 Johnson & Johnson Company Information, Head Office, Market Area and Industry Position

9.14.2 Johnson & Johnson Company Profile and Main Business

9.14.3 Johnson & Johnson Precision Cancer Therapeutics Models, Specifications and Application

9.14.4 Johnson & Johnson Precision Cancer Therapeutics Revenue and Gross Margin, 2019-2024

9.14.5 Johnson & Johnson Recent Developments

9.15 Merck & Co., Inc.

9.15.1 Merck & Co., Inc. Company Information, Head Office, Market Area and Industry Position

9.15.2 Merck & Co., Inc. Company Profile and Main Business

9.15.3 Merck & Co., Inc. Precision Cancer Therapeutics Models, Specifications and Application

9.15.4 Merck & Co., Inc. Precision Cancer Therapeutics Revenue and Gross Margin, 2019-2024

9.15.5 Merck & Co., Inc. Recent Developments

9.16 Novartis AG

9.16.1 Novartis AG Company Information, Head Office, Market Area and Industry Position

9.16.2 Novartis AG Company Profile and Main Business

9.16.3 Novartis AG Precision Cancer Therapeutics Models, Specifications and Application

9.16.4 Novartis AG Precision Cancer Therapeutics Revenue and Gross Margin, 2019-2024

9.16.5 Novartis AG Recent Developments

9.17 Otsuka Holdings Co., Ltd.

9.17.1 Otsuka Holdings Co., Ltd. Company Information, Head Office, Market Area and Industry Position

9.17.2 Otsuka Holdings Co., Ltd. Company Profile and Main Business

9.17.3 Otsuka Holdings Co., Ltd. Precision Cancer Therapeutics Models, Specifications and Application

9.17.4 Otsuka Holdings Co., Ltd. Precision Cancer Therapeutics Revenue and Gross Margin, 2019-2024

9.17.5 Otsuka Holdings Co., Ltd. Recent Developments

9.18 Pfizer, Inc.

9.18.1 Pfizer, Inc. Company Information, Head Office, Market Area and Industry Position

9.18.2 Pfizer, Inc. Company Profile and Main Business

9.18.3 Pfizer, Inc. Precision Cancer Therapeutics Models, Specifications and Application

9.18.4 Pfizer, Inc. Precision Cancer Therapeutics Revenue and Gross Margin, 2019-2024

9.18.5 Pfizer, Inc. Recent Developments

9.19 Puma Biotechnology, Inc.

9.19.1 Puma Biotechnology, Inc. Company Information, Head Office, Market Area and Industry Position

9.19.2 Puma Biotechnology, Inc. Company Profile and Main Business

9.19.3 Puma Biotechnology, Inc. Precision Cancer Therapeutics Models, Specifications and Application

9.19.4 Puma Biotechnology, Inc. Precision Cancer Therapeutics Revenue and Gross Margin, 2019-2024

9.19.5 Puma Biotechnology, Inc. Recent Developments

9.20 Roche (F. Hoffman-La Roche, Ltd.)

9.20.1 Roche (F. Hoffman-La Roche, Ltd.) Company Information, Head Office, Market Area and Industry Position

9.20.2 Roche (F. Hoffman-La Roche, Ltd.) Company Profile and Main Business

9.20.3 Roche (F. Hoffman-La Roche, Ltd.) Precision Cancer Therapeutics Models, Specifications and Application

9.20.4 Roche (F. Hoffman-La Roche, Ltd.) Precision Cancer Therapeutics Revenue and Gross Margin, 2019-2024

9.20.5 Roche (F. Hoffman-La Roche, Ltd.) Recent Developments

9.21 Sanofi/Genzyme

9.21.1 Sanofi/Genzyme Company Information, Head Office, Market Area and Industry Position

9.21.2 Sanofi/Genzyme Company Profile and Main Business

9.21.3 Sanofi/Genzyme Precision Cancer Therapeutics Models, Specifications and Application

9.21.4 Sanofi/Genzyme Precision Cancer Therapeutics Revenue and Gross Margin, 2019-2024

9.21.5 Sanofi/Genzyme Recent Developments

9.22 Seagen Inc.

9.22.1 Seagen Inc. Company Information, Head Office, Market Area and Industry Position

9.22.2 Seagen Inc. Company Profile and Main Business

9.22.3 Seagen Inc. Precision Cancer Therapeutics Models, Specifications and Application

9.22.4 Seagen Inc. Precision Cancer Therapeutics Revenue and Gross Margin, 2019-2024

9.22.5 Seagen Inc. Recent Developments

9.23 Takeda

9.23.1 Takeda Company Information, Head Office, Market Area and Industry Position

9.23.2 Takeda Company Profile and Main Business

9.23.3 Takeda Precision Cancer Therapeutics Models, Specifications and Application

9.23.4 Takeda Precision Cancer Therapeutics Revenue and Gross Margin, 2019-2024

9.23.5 Takeda Recent Developments

10 Conclusion

11 Appendix

11.1 Research Methodology

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Market Estimation Model

11.4 Disclaimer

Table 1. Precision Cancer Therapeutics Market Size & CAGR: China VS Global, (US$ Million), 2019-2030

Table 2. Precision Cancer Therapeutics Market Restraints

Table 3. Precision Cancer Therapeutics Market Trends

Table 4. Precision Cancer Therapeutics Industry Policy

Table 5. Global Precision Cancer Therapeutics Revenue by Company (2019-2024) & (US$ million)

Table 6. Global Precision Cancer Therapeutics Revenue Market Share by Company (2019-2024)

Table 7. Global Precision Cancer Therapeutics Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Precision Cancer Therapeutics Mergers & Acquisitions, Expansion Plans

Table 9. Global Precision Cancer Therapeutics Manufacturers Product Type

Table 10. China Precision Cancer Therapeutics Revenue by Company (2019-2024) & (US$ million)

Table 11. China Precision Cancer Therapeutics Revenue Market Share by Company (2019-2024)

Table 12. Global Key Players of Precision Cancer Therapeutics Upstream (Raw Materials)

Table 13. Global Precision Cancer Therapeutics Typical Customers

Table 14. Precision Cancer Therapeutics Typical Distributors

Table 15. By Type, Global Precision Cancer Therapeutics Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 16. By Application, Global Precision Cancer Therapeutics Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 17. By Region, Global Precision Cancer Therapeutics Market Size, 2019 VS 2024 VS 2030, US$ Million

Table 18. By Region, Global Precision Cancer Therapeutics Revenue, 2019-2030, US$ Million

Table 19. By Country, Global Precision Cancer Therapeutics Revenue & CAGR，2019 VS 2024 VS 2030, US$ Million

Table 20. By Country, Global Precision Cancer Therapeutics Revenue, 2019-2030, US$ Million

Table 21. By Country, Global Precision Cancer Therapeutics Revenue Market Share, 2019-2030

Table 22. AbbVie Company Information, Head Office, Market Area and Industry Position

Table 23. AbbVie Company Profile and Main Business

Table 24. AbbVie Precision Cancer Therapeutics Models, Specifications and Application

Table 25. AbbVie Precision Cancer Therapeutics Revenue and Gross Margin, 2019-2024

Table 26. AbbVie Recent Developments

Table 27. Astellas Pharma U.S., Inc Company Information, Head Office, Market Area and Industry Position

Table 28. Astellas Pharma U.S., Inc Company Profile and Main Business

Table 29. Astellas Pharma U.S., Inc Precision Cancer Therapeutics Models, Specifications and Application

Table 30. Astellas Pharma U.S., Inc Precision Cancer Therapeutics Revenue and Gross Margin, 2019-2024

Table 31. Astellas Pharma U.S., Inc Recent Developments

Table 32. AstraZeneca PLC Company Information, Head Office, Market Area and Industry Position

Table 33. AstraZeneca PLC Company Profile and Main Business

Table 34. AstraZeneca PLC Precision Cancer Therapeutics Models, Specifications and Application

Table 35. AstraZeneca PLC Precision Cancer Therapeutics Revenue and Gross Margin, 2019-2024

Table 36. AstraZeneca PLC Recent Developments

Table 37. Bayer AG Company Information, Head Office, Market Area and Industry Position

Table 38. Bayer AG Company Profile and Main Business

Table 39. Bayer AG Precision Cancer Therapeutics Models, Specifications and Application

Table 40. Bayer AG Precision Cancer Therapeutics Revenue and Gross Margin, 2019-2024

Table 41. Bayer AG Recent Developments

Table 42. Bristol-Myers Squibb Company Company Information, Head Office, Market Area and Industry Position

Table 43. Bristol-Myers Squibb Company Company Profile and Main Business

Table 44. Bristol-Myers Squibb Company Precision Cancer Therapeutics Models, Specifications and Application

Table 45. Bristol-Myers Squibb Company Precision Cancer Therapeutics Revenue and Gross Margin, 2019-2024

Table 46. Bristol-Myers Squibb Company Recent Developments

Table 47. Clovis Oncology, Inc. Company Information, Head Office, Market Area and Industry Position

Table 48. Clovis Oncology, Inc. Company Profile and Main Business

Table 49. Clovis Oncology, Inc. Precision Cancer Therapeutics Models, Specifications and Application

Table 50. Clovis Oncology, Inc. Precision Cancer Therapeutics Revenue and Gross Margin, 2019-2024

Table 51. Clovis Oncology, Inc. Recent Developments

Table 52. Dendreon Pharmaceuticals LLC Company Information, Head Office, Market Area and Industry Position

Table 53. Dendreon Pharmaceuticals LLC Company Profile and Main Business

Table 54. Dendreon Pharmaceuticals LLC Precision Cancer Therapeutics Models, Specifications and Application

Table 55. Dendreon Pharmaceuticals LLC Precision Cancer Therapeutics Revenue and Gross Margin, 2019-2024

Table 56. Dendreon Pharmaceuticals LLC Recent Developments

Table 57. Eli Lilly & Company Company Information, Head Office, Market Area and Industry Position

Table 58. Eli Lilly & Company Company Profile and Main Business

Table 59. Eli Lilly & Company Precision Cancer Therapeutics Models, Specifications and Application

Table 60. Eli Lilly & Company Precision Cancer Therapeutics Revenue and Gross Margin, 2019-2024

Table 61. Eli Lilly & Company Recent Developments

Table 62. EMD Serono, Inc. (Merck KgaA) Company Information, Head Office, Market Area and Industry Position

Table 63. EMD Serono, Inc. (Merck KgaA) Company Profile and Main Business

Table 64. EMD Serono, Inc. (Merck KgaA) Precision Cancer Therapeutics Models, Specifications and Application

Table 65. EMD Serono, Inc. (Merck KgaA) Precision Cancer Therapeutics Revenue and Gross Margin, 2019-2024

Table 66. EMD Serono, Inc. (Merck KgaA) Recent Developments

Table 67. Eisai Co., Ltd. Company Information, Head Office, Market Area and Industry Position

Table 68. Eisai Co., Ltd. Company Profile and Main Business

Table 69. Eisai Co., Ltd. Precision Cancer Therapeutics Models, Specifications and Application

Table 70. Eisai Co., Ltd. Precision Cancer Therapeutics Revenue and Gross Margin, 2019-2024

Table 71. Eisai Co., Ltd. Recent Developments

Table 72. Exelixis, Inc. Company Information, Head Office, Market Area and Industry Position

Table 73. Exelixis, Inc. Company Profile and Main Business

Table 74. Exelixis, Inc. Precision Cancer Therapeutics Models, Specifications and Application

Table 75. Exelixis, Inc. Precision Cancer Therapeutics Revenue and Gross Margin, 2019-2024

Table 76. Exelixis, Inc. Recent Developments

Table 77. Gilead Sciences, Inc. Company Information, Head Office, Market Area and Industry Position

Table 78. Gilead Sciences, Inc. Company Profile and Main Business

Table 79. Gilead Sciences, Inc. Precision Cancer Therapeutics Models, Specifications and Application

Table 80. Gilead Sciences, Inc. Precision Cancer Therapeutics Revenue and Gross Margin, 2019-2024

Table 81. Gilead Sciences, Inc. Recent Developments

Table 82. GlaxoSmithKline Company Information, Head Office, Market Area and Industry Position

Table 83. GlaxoSmithKline Company Profile and Main Business

Table 84. GlaxoSmithKline Precision Cancer Therapeutics Models, Specifications and Application

Table 85. GlaxoSmithKline Precision Cancer Therapeutics Revenue and Gross Margin, 2019-2024

Table 86. GlaxoSmithKline Recent Developments

Table 87. Johnson & Johnson Company Information, Head Office, Market Area and Industry Position

Table 88. Johnson & Johnson Company Profile and Main Business

Table 89. Johnson & Johnson Precision Cancer Therapeutics Models, Specifications and Application

Table 90. Johnson & Johnson Precision Cancer Therapeutics Revenue and Gross Margin, 2019-2024

Table 91. Johnson & Johnson Recent Developments

Table 92. Merck & Co., Inc. Company Information, Head Office, Market Area and Industry Position

Table 93. Merck & Co., Inc. Company Profile and Main Business

Table 94. Merck & Co., Inc. Precision Cancer Therapeutics Models, Specifications and Application

Table 95. Merck & Co., Inc. Precision Cancer Therapeutics Revenue and Gross Margin, 2019-2024

Table 96. Merck & Co., Inc. Recent Developments

Table 97. Novartis AG Company Information, Head Office, Market Area and Industry Position

Table 98. Novartis AG Company Profile and Main Business

Table 99. Novartis AG Precision Cancer Therapeutics Models, Specifications and Application

Table 100. Novartis AG Precision Cancer Therapeutics Revenue and Gross Margin, 2019-2024

Table 101. Novartis AG Recent Developments

Table 102. Otsuka Holdings Co., Ltd. Company Information, Head Office, Market Area and Industry Position

Table 103. Otsuka Holdings Co., Ltd. Company Profile and Main Business

Table 104. Otsuka Holdings Co., Ltd. Precision Cancer Therapeutics Models, Specifications and Application

Table 105. Otsuka Holdings Co., Ltd. Precision Cancer Therapeutics Revenue and Gross Margin, 2019-2024

Table 106. Otsuka Holdings Co., Ltd. Recent Developments

Table 107. Pfizer, Inc. Company Information, Head Office, Market Area and Industry Position

Table 108. Pfizer, Inc. Company Profile and Main Business

Table 109. Pfizer, Inc. Precision Cancer Therapeutics Models, Specifications and Application

Table 110. Pfizer, Inc. Precision Cancer Therapeutics Revenue and Gross Margin, 2019-2024

Table 111. Pfizer, Inc. Recent Developments

Table 112. Puma Biotechnology, Inc. Company Information, Head Office, Market Area and Industry Position

Table 113. Puma Biotechnology, Inc. Company Profile and Main Business

Table 114. Puma Biotechnology, Inc. Precision Cancer Therapeutics Models, Specifications and Application

Table 115. Puma Biotechnology, Inc. Precision Cancer Therapeutics Revenue and Gross Margin, 2019-2024

Table 116. Puma Biotechnology, Inc. Recent Developments

Table 117. Roche (F. Hoffman-La Roche, Ltd.) Company Information, Head Office, Market Area and Industry Position

Table 118. Roche (F. Hoffman-La Roche, Ltd.) Company Profile and Main Business

Table 119. Roche (F. Hoffman-La Roche, Ltd.) Precision Cancer Therapeutics Models, Specifications and Application

Table 120. Roche (F. Hoffman-La Roche, Ltd.) Precision Cancer Therapeutics Revenue and Gross Margin, 2019-2024

Table 121. Roche (F. Hoffman-La Roche, Ltd.) Recent Developments

Table 122. Sanofi/Genzyme Company Information, Head Office, Market Area and Industry Position

Table 123. Sanofi/Genzyme Company Profile and Main Business

Table 124. Sanofi/Genzyme Precision Cancer Therapeutics Models, Specifications and Application

Table 125. Sanofi/Genzyme Precision Cancer Therapeutics Revenue and Gross Margin, 2019-2024

Table 126. Sanofi/Genzyme Recent Developments

Table 127. Seagen Inc. Company Information, Head Office, Market Area and Industry Position

Table 128. Seagen Inc. Company Profile and Main Business

Table 129. Seagen Inc. Precision Cancer Therapeutics Models, Specifications and Application

Table 130. Seagen Inc. Precision Cancer Therapeutics Revenue and Gross Margin, 2019-2024

Table 131. Seagen Inc. Recent Developments

Table 132. Takeda Company Information, Head Office, Market Area and Industry Position

Table 133. Takeda Company Profile and Main Business

Table 134. Takeda Precision Cancer Therapeutics Models, Specifications and Application

Table 135. Takeda Precision Cancer Therapeutics Revenue and Gross Margin, 2019-2024

Table 136. Takeda Recent Developments

List of Figure

Figure 1. Precision Cancer Therapeutics Picture

Figure 2. Global Precision Cancer Therapeutics Industry Market Size and Forecast (US$ million) & (2019-2030)

Figure 3. China Precision Cancer Therapeutics Revenue and Forecast (US$ million) & (2019-2030)

Figure 4. 2019-2030 China Precision Cancer Therapeutics Market Share of Global

Figure 5. Global Precision Cancer Therapeutics Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 6. Global Precision Cancer Therapeutics Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2019-2024

Figure 7. China Precision Cancer Therapeutics Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 8. China Precision Cancer Therapeutics Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024

Figure 9. Precision Cancer Therapeutics Industry Chain

Figure 10. Monoclonal Antibodies

Figure 11. Kinase Inhibitors

Figure 12. Angiogenesis Inhibitors

Figure 13. Proteasome Inhibitors

Figure 14. CAR-T Therapies

Figure 15. Other Precision Therapies

Figure 16. By Type, Global Precision Cancer Therapeutics Revenue, 2019-2030, US$ Million

Figure 17. By Type, Global Precision Cancer Therapeutics Revenue Market Share, 2019-2030

Figure 18. Breast Cancer

Figure 19. Lung Cancer

Figure 20. Prostate Cancer

Figure 21. Colon and Rectal Cancer

Figure 22. Others

Figure 23. By Application, Global Precision Cancer Therapeutics Revenue, 2019-2030, US$ Million

Figure 24. By Application, Global Precision Cancer Therapeutics Revenue Market Share, 2019-2030

Figure 25. By Region, Global Precision Cancer Therapeutics Revenue Market Share, 2019-2030

Figure 26. North America Precision Cancer Therapeutics Revenue & Forecasts, 2019-2030, US$ Million

Figure 27. By Country, North America Precision Cancer Therapeutics Revenue Market Share, 2019-2024

Figure 28. Europe Precision Cancer Therapeutics Revenue & Forecasts, 2019-2030, US$ Million

Figure 29. By Country, Europe Precision Cancer Therapeutics Revenue Market Share, 2019-2024

Figure 30. Asia Pacific Precision Cancer Therapeutics Revenue & Forecasts, 2019-2030, US$ Million

Figure 31. By Country/Region, Asia Pacific Precision Cancer Therapeutics Revenue Market Share, 2019-2024

Figure 32. South America Precision Cancer Therapeutics Revenue & Forecasts, 2019-2030, US$ Million

Figure 33. By Country, South America Precision Cancer Therapeutics Revenue Market Share, 2019-2024

Figure 34. Middle East & Africa Precision Cancer Therapeutics Revenue & Forecasts, 2019-2030, US$ Million

Figure 35. U.S. Precision Cancer Therapeutics Revenue, 2019-2030, (US$ Million)

Figure 36. By Company, U.S. Precision Cancer Therapeutics Market Share, 2019-2024

Figure 37. By Type, U.S. Precision Cancer Therapeutics Revenue Market Share, 2022 VS 2029

Figure 38. By Application, U.S. Precision Cancer Therapeutics Revenue Market Share, 2022 VS 2029

Figure 39. Europe Precision Cancer Therapeutics Revenue, 2019-2030, (US$ Million)

Figure 40. By Company, Europe Precision Cancer Therapeutics Market Share, 2019-2024

Figure 41. By Type, Europe Precision Cancer Therapeutics Revenue Market Share, 2022 VS 2029

Figure 42. By Application, Europe Precision Cancer Therapeutics Revenue Market Share, 2022 VS 2029

Figure 43. China Precision Cancer Therapeutics Revenue, 2019-2030, (US$ Million)

Figure 44. By Company, China Precision Cancer Therapeutics Market Share, 2019-2024

Figure 45. By Type, China Precision Cancer Therapeutics Revenue Market Share, 2022 VS 2029

Figure 46. By Application, China Precision Cancer Therapeutics Revenue Market Share, 2022 VS 2029

Figure 47. Japan Precision Cancer Therapeutics Revenue, 2019-2030, (US$ Million)

Figure 48. By Company, Japan Precision Cancer Therapeutics Market Share, 2019-2024

Figure 49. By Type, Japan Precision Cancer Therapeutics Revenue Market Share, 2022 VS 2029

Figure 50. By Application, Japan Precision Cancer Therapeutics Revenue Market Share, 2022 VS 2029

Figure 51. South Korea Precision Cancer Therapeutics Revenue, 2019-2030, (US$ Million)

Figure 52. By Company, South Korea Precision Cancer Therapeutics Market Share, 2019-2024

Figure 53. By Type, South Korea Precision Cancer Therapeutics Revenue Market Share, 2022 VS 2029

Figure 54. By Application, South Korea Precision Cancer Therapeutics Revenue Market Share, 2022 VS 2029

Figure 55. Southeast Asia Precision Cancer Therapeutics Revenue, 2019-2030, (US$ Million)

Figure 56. By Company, Southeast Asia Precision Cancer Therapeutics Market Share, 2019-2024

Figure 57. By Type, Southeast Asia Precision Cancer Therapeutics Revenue Market Share, 2022 VS 2029

Figure 58. By Application, Southeast Asia Precision Cancer Therapeutics Revenue Market Share, 2022 VS 2029

Figure 59. India Precision Cancer Therapeutics Revenue, 2019-2030, (US$ Million)

Figure 60. By Company, India Precision Cancer Therapeutics Market Share, 2019-2024

Figure 61. By Type, India Precision Cancer Therapeutics Revenue Market Share, 2022 VS 2029

Figure 62. By Application, India Precision Cancer Therapeutics Revenue Market Share, 2022 VS 2029

Figure 63. Middle East & Asia Precision Cancer Therapeutics Revenue, 2019-2030, (US$ Million)

Figure 64. By Company, Middle East & Asia Precision Cancer Therapeutics Market Share, 2019-2024

Figure 65. By Type, Middle East & Asia Precision Cancer Therapeutics Revenue Market Share, 2022 VS 2029

Figure 66. By Application, Middle East & Asia Precision Cancer Therapeutics Revenue Market Share, 2022 VS 2029

Figure 67. Research Methodology

Figure 68. Breakdown of Primary Interviews

Figure 69. Bottom-up Approaches

Figure 70. Top-down Approaches

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)